Molecular Pathology, Diagnostics, and Therapeutics
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to enable rapid publication of contributions on all aspects of molecular pathology, ranging from basic research at the molecular level, to clinical and forensic applications. We welcome studies on molecular mechanisms, diagnostics, and therapeutics of human disease and relevant experimental models using cellular, molecular, biological, chemical and immunological approaches. Topics include, but are not limited to:
- the molecular and cellular mechanism of diseases and injury
- immunopathology and diseases
- mechanisms of immunotoxicity
- matrix pathobiology
- in vitro and in vivo aspects of inflammation and autophagy
- mechanism of tissue alterations
- mechanisms of genotoxicity
- musculoskeletal pathology
- molecular diagnostics
- molecular targeted therapy
- cell injury, repair, aging and apoptosis
- stem cell or gene therapy
- novel mechanisms of carcinogenesis
- application of molecular pathology to tissue identification
We also welcome reviews on these subjects, particularly those that challenge existing concepts.
Keywords
Cardiovascular disease; pneumonia; kidney; cardiotoxicity of non-cardiac drugs; mitochondria; gastrointestinal tract, hepatobiliary and pancreas; B and T-cell; infectious diseases; inflammation; immunotoxicity; tissue alterations; metabolism, endocrine and urogenital; genotoxicity; musculoskeletal; pharmacogenomics; gene therapy; stem cells; DNA damaging; cancer; atherosclerosis; endothelium
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Novel MSC Perspectives: From Cell Regulation to Tissue Regeneration 2.0 (Deadline: 10 June 2020)
- Biomarkers of Renal Diseases (Deadline: 30 June 2020)
- Mucopolysaccharidoses: Diagnosis, Treatment, and Management (Deadline: 30 June 2020)
- Sickle Cell Disease: From Pathogenesis to Therapies (Deadline: 30 June 2020)
- Cardiovascular Complications of Diabetes (Deadline: 30 June 2020)
- Role and Application of Stem Cells in Regenerative Medicine 2.0 (Deadline: 30 June 2020)
- Bone Marrow and Stem Cell Alterations in Diabetes: Causes, Consequences and Therapeutics (Deadline: 30 June 2020)
- Glycosylation-Based Biomarkers in Diseases and Drug Delivery (Deadline: 30 June 2020)
- Genetically Engineered Mice to Study Cancer (Deadline: 30 June 2020)
- Transglutaminase Diseases, from the Experimental Laboratory to Human Pathology Applications (Deadline: 30 June 2020)
- Signaling Pathways of Skin Tumors (Deadline: 30 June 2020)
- Natural Killer and NKT Cells 2020 (Deadline: 30 June 2020)
- New Advances in the Pathogenesis, Diagnosis and Treatment of NMOSD (Deadline: 30 June 2020)
- Host-Cytomegalovirus Interactions: Pro- and Antiviral Key Factors Affecting CMV Infection Outcome or Therapeutic Approaches 2.0 (Deadline: 30 June 2020)
- Molecular Mechanism of Vascular Disorders and Thrombosis (Deadline: 30 June 2020)
- Galectins in Cancer and Translational Research 2.0 (Deadline: 30 June 2020)
- Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery (Deadline: 30 June 2020)
- Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction (Deadline: 30 June 2020)
- Role of Mitochondrial Dysfunction in the Pathogenesis of Cardiovascular Diseases (Deadline: 30 June 2020)
- Histone Deacetylase Inhibitors in Health and Disease II (Deadline: 30 June 2020)
- Kidney Injury: From Molecular Basis to Therapies 2.0 (Deadline: 30 June 2020)
- Molecular Mechanisms Regulating Osteoclastogenesis (Deadline: 30 June 2020)
- Molecular Research On Abdominal Aortic Aneurysm (Deadline: 30 June 2020)
- Therapy Personalization in Pediatric Diseases: From Molecular Biology to Therapy (Deadline: 30 June 2020)
- New Frontiers in Organ Preservation and Hepatoprotection (Deadline: 30 June 2020)
- Recent Advances of Proteomics Applied to Cancer and Human Diseases (Deadline: 30 June 2020)
- Regulatory Role of PPARs in the Disease (Deadline: 30 June 2020)
- Exosomes in Cancer Diagnosis and Therapy (Deadline: 30 June 2020)
- hiPSC-Derived Cells as Models for Drug Discovery (Deadline: 30 June 2020)
- Non-ionizing Radiations: Biological Effects and Interaction Mechanisms (Deadline: 30 June 2020)
- The Cord-Age-Gender Connection in Multiple Sclerosis Pathophysiology (Deadline: 30 June 2020)
- Biomolecular Mediators in Cardiomyopathies (Deadline: 10 July 2020)
- Advances in the Pathobiology and Treatment of Hodgkin Lymphoma (Deadline: 10 July 2020)
- Recent Advances in the Diagnosis and Treatment of Chronic Liver Diseases (Deadline: 15 July 2020)
- Endothelial Progenitor Cells in Health and Disease (Deadline: 15 July 2020)
- Tyrosine Kinases in Health and Disease (Deadline: 30 July 2020)
- Integrin Signaling and Human Pathologies 2.0 (Deadline: 30 July 2020)
- Redox Regulation of Cardiovascular Metabolism and Inflammation (Deadline: 30 July 2020)
- Thyroid Hormones and NAFLD: New Insights (Deadline: 31 July 2020)
- Therapeutic Approaches for Aging-Related Lung Disease (Deadline: 31 July 2020)
- Molecular Mechanism and Pathogenesis of Antiphospholipid Syndrome (Deadline: 31 July 2020)
- Molecular Mechanisms of Insulin Resistance in Peripheral Tissues (Deadline: 31 July 2020)
- Epigenetic, microRNA and Long Non-Coding RNA Roles in Osteoporosis (Deadline: 31 July 2020)
- Pharmacological and Technological Advances for the Treatment of Diabetes and Other Metabolic Diseases (Deadline: 31 July 2020)
- RNPs (Ribonucleoproteins) in Human Physiology and Disease Processes (Deadline: 31 July 2020)
- Pathophisiology and Treatment of Stroke: Present Status and Future Perspective (Deadline: 31 July 2020)
- Molecular Research in Endoplasmic Reticulum Storage Diseases and Related Disease (Deadline: 31 July 2020)
- Target Dysfunctional Inflammation in Cystic Fibrosis Airway (Deadline: 31 July 2020)
- Epilepsy: From Molecular Mechanisms to Targeted Therapies 2.0 (Deadline: 31 July 2020)
- Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics (Deadline: 31 July 2020)
- Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer – Illumination of a Vision 2.0 (Deadline: 31 July 2020)
- Blood-Derived Products for Tissue Repair/Regeneration 2.0 (Deadline: 31 July 2020)
- Salivary Biomarkers and Their Application to Diagnosis and Monitoring Human Diseases (Deadline: 31 July 2020)
- Oral Cancer—Diagnosis and Therapeutics 2020 (Deadline: 31 July 2020)
- Role of ncRNAs Classes as Biomarkers for Diagnostic and Prognosis in Cancer (Deadline: 31 July 2020)
- Antibody-Drug Conjugates for the Treatment of Neoplastic Disorders (Deadline: 31 July 2020)
- Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated (Deadline: 31 July 2020)
- Mechanisms and Therapeutics of Platelet Thrombus Formation 2020 (Deadline: 31 July 2020)
- Cellular and Molecular Mechanisms of Hematopoiesis (Deadline: 31 July 2020)
- Osteoclast Multinucleation Mechanisms (Deadline: 31 July 2020)
- Wound Repair and Regeneration 2.0 (Deadline: 31 July 2020)
- Role of Hyaluronan, Hyaluronan Receptors and Binding Partners in Health and Disease (Deadline: 31 July 2020)
- Medicines for the Treatment of Obesity (Deadline: 31 July 2020)
- Molecular Research in Emerging Viruses 2020 (Deadline: 31 July 2020)
- MicroRNAs and Stem Cells 2.0 (Deadline: 31 July 2020)
- Pathophysiology of Neuropsychiatric Disease (Deadline: 31 July 2020)
- Sleep Apnoea and Comorbidity: A Molecular Approache, Treatment, and Clinical Implications (Deadline: 31 July 2020)
- Molecular Research in Gerontology and Geriatrics (Deadline: 31 July 2020)
- Molecular and Cellular Hallmarks of Malignant Brain Tumors (Deadline: 31 July 2020)
- Research of Pathogenesis and Novel Therapeutics in Arthritis 2.0 (Deadline: 5 August 2020)
- Multiple Myeloma Bone Disease—Symptoms, Diagnosis and Treatment (Deadline: 15 August 2020)
- Achilles Curse and Remedy: Tendon Diseases from Pathophysiology to Novel Therapeutic Approaches (Deadline: 15 August 2020)
- Acute Lung Injury – New Insights into the Mechanisms and Emerging Therapies 2.0 (Deadline: 20 August 2020)
- Protein Folding Diseases—Molecular Mechanisms and Therapeutic Approaches (Deadline: 20 August 2020)
- Natural Medicines for Women’s Menopausal Symptoms: Molecular Mechanisms and Effects (Deadline: 25 August 2020)
- Dental Pulp Stem Cells: Unveiling Their Multifaceted Therapeutic Potential (Deadline: 27 August 2020)
- Targeting Mitochondria in Aging and Disease (Deadline: 30 August 2020)
- Molecular Biology of Brain Tumors (Deadline: 30 August 2020)
- The Therapeutic Usage of Natural Product-Derived Medicine in Oxidative Stress-Induced Diseases (Deadline: 31 August 2020)
- Boundaries of Cancer and Cardiovascular Diseases (Deadline: 31 August 2020)
- Molecular Mechanisms of Asthma (Deadline: 31 August 2020)
- Kidney Inflammation, Injury and Regeneration 2020 (Deadline: 31 August 2020)
- Role of Drosophila in Human Disease Research (Deadline: 31 August 2020)
- Biomarker-Oriented Treatment of Urogenital Cancers (Deadline: 31 August 2020)
- Molecular Research in Inflammatory Bowel Disease 2.0 (Deadline: 31 August 2020)
- Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 2.0 (Deadline: 31 August 2020)
- Cell-Free Nucleic Acids in the Molecular Pathogenesis of Diseases Development (Deadline: 31 August 2020)
- Biomarkers in Rare Diseases (Deadline: 31 August 2020)
- Pro-inflammatory and Anti-inflammatory Cytokines in Autoimmune Diseases (Deadline: 31 August 2020)
- Therapy and Prevention of Atopic Dermatitis and Psoriasis 2020 (Deadline: 31 August 2020)
- Molecular Biomarkers of Selected Diseases of Civilization (Deadline: 31 August 2020)
- Polycystic Ovary Syndrome: From Molecular Mechanisms to Therapies (Deadline: 31 August 2020)
- Effects of Polyphenols on Cardiac Mitochondrial Function: Possible Implications in the Diabetic Heart (Deadline: 31 August 2020)
- Nuclear Medicine for Prediction of Therapy Efficacy and Therapeutic Evaluation in Oncology (Deadline: 31 August 2020)
- Molecular Psychiatry 2.0 (Deadline: 31 August 2020)
- BCR-ABL1 Negative Myeloproliferative Neoplasms (Deadline: 31 August 2020)
- Angiotensin Converting Enzyme 2 (ACE2): Cellular and Clinical Aspects of an Underused Pharmacological Target (Deadline: 31 August 2020)
- Physiological and Pathological Roles of ABC Transporters 2.0 (Deadline: 31 August 2020)
- Osteoporosis: From Molecular Mechanisms to Therapies 2.0 (Deadline: 31 August 2020)
- Molecular Mechanisms, Pharmacology, Toxicology Involved in Cardiac Function and Dysfunction (Deadline: 31 August 2020)
- FAK Signaling Pathway and Interaction Networks in Diseases (Deadline: 31 August 2020)
- Pancreatic Ductal Adenocarcinoma: Precursors and Variants (Deadline: 31 August 2020)
- The Role of Polymorphic Variation in Non-coding DNA in Predicting Disease (Deadline: 31 August 2020)
- Hypoxia Signaling in Human Diseases (Deadline: 31 August 2020)
- Molecular Pathogenesis of Viral Hepatitis and Liver Cancer (Deadline: 31 August 2020)
- Peripheral Targets in Obesity: Pathologies and Therapeutics (Deadline: 31 August 2020)
- Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges 2.0 (Deadline: 1 September 2020)
- Translating Gold Nanoparticles to Diagnostics and Therapeutics 3.0 (Deadline: 7 September 2020)
- NF-κB and Disease (Deadline: 10 September 2020)
- Emerging OMICS Approaches to Studying the Eye in the Norm and Pathology 2.0 (Deadline: 10 September 2020)
- Molecular Research on Stress Response and Ocular Homeostasis (Deadline: 15 September 2020)
- Genetic and Metabolic Molecular Research of Lysosomal Storage Disease (Deadline: 30 September 2020)
- Cell Programming for Cardiovascular Disease Modeling and Therapy (Deadline: 30 September 2020)
- Anti-viral Therapy for Chronic Hepatitis (Deadline: 30 September 2020)
- Selected Papers of Workshop "Osteoarthritis: Novel Molecular Determinants Revolutionize Our Understanding of the Disease Pathology" (Deadline: 30 September 2020)
- Erythropoietin (Deadline: 30 September 2020)
- Molecular Mechanisms of Obesity-Associated Vascular Disease (Deadline: 30 September 2020)
- Calcification in Human Pathology (Deadline: 30 September 2020)
- Molecular Regulation of Exercise on Adipose Tissue and Related Diseases (Deadline: 30 September 2020)
- Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy (Deadline: 30 September 2020)
- Neuroimmune Interactions (Deadline: 30 September 2020)
- Myocardial Infarction and Myocardial Protection (Deadline: 30 September 2020)
- Tumor Microenvironment and Actin Cytoskeleton in Cancer Cell Metastasis (Deadline: 30 September 2020)
- Molecular Mechanisms Involved in Diabetic Nephropathy (Deadline: 30 September 2020)
- Molecular Research on Light's Effects on Animals and Humans (Deadline: 30 September 2020)
- Apoptosis and Autophagy: The Double Edge in Cancer Development and Progression and in Other Human Diseases 2.0 (Deadline: 30 September 2020)
- Recent Advancements in Research and Therapy of Ocular Neovascular Diseases (Deadline: 30 September 2020)
- Molecular Research on Arboviruses Infection (Deadline: 30 September 2020)
- Molecular Research On Platelet Activity in Health and Disease 2.0 (Deadline: 30 September 2020)
- Therapeutic Strategies and Targets for Reactive Oxygen Species Related Diseases (Deadline: 30 September 2020)
- Molecular Research on Celiac Disease (Deadline: 30 September 2020)
- Liver Diseases: Causes, Molecular Mechanisms and Treatment/Prevention (Deadline: 30 September 2020)
- Novel Approaches to Hematologic Malignancies by Immunotherapy (Deadline: 30 September 2020)
- Bone Development and Regeneration (Deadline: 30 September 2020)
- Muscle Atrophy: Discovery of Mechanisms and Potential Therapies (Deadline: 30 September 2020)
- Pathogenesis and Treatment of Leukemia and Myelodysplastic Syndromes (Deadline: 30 September 2020)
- Omics Biomarker in Multiple Sclerosis (Deadline: 30 September 2020)
- Ras Subfamily and Regulators in Human Disease and Repair (Deadline: 30 September 2020)
- Protein Kinases: Function, Substrates, and Implication in Diseases (Deadline: 30 September 2020)
- Elucidation of Leaky Gut Syndrome and the Discovery of Therapeutic Targets (Deadline: 30 September 2020)
- Molecular and Tissue Engineering Approaches in Musculoskeletal Regenerative Medicine 2.0 (Deadline: 30 September 2020)
- Purinergic Signaling in Neuroinflammation (Deadline: 30 September 2020)
- Molecular Medicine Research on Inherited Metabolic Disorders (Deadline: 30 September 2020)
- G Protein-Coupled Receptor and Their Kinases in Cell Biology and Disease (Deadline: 30 September 2020)
- Therapeutic Molecular Targets in Tumor Microenvironment (Deadline: 30 September 2020)
- Intracellular Calcium Levels and Cell Fate in Cancer: Interplay between Senescence, Autophagy and Apoptosis (Deadline: 30 September 2020)
- Advances in Molecular Biology and Targeted Therapy of Leukemias 2.0 (Deadline: 30 September 2020)
- Nutrigenomics in Liver Diseases: An Uncharted Territory (Deadline: 30 September 2020)
- Molecular Research on Cognitive Function in the Elderly (Deadline: 30 September 2020)
- Lung Diseases and Infections in the New Era 2.0 (Deadline: 30 September 2020)
- The Role of Long Non-Coding RNAs in Inflammation and Chronic Inflammatory Diseases (Deadline: 30 September 2020)
- Functional Foods for Obesity—from Mechanisms to Treatments (Deadline: 30 September 2020)
- Interventions Affecting the Mitochondrial Control of Longevity and Health (Deadline: 30 September 2020)
- Inflammatory Skin Conditions 2020 (Deadline: 30 September 2020)
- Hepatocyte Growth Factor (HGF), II (Deadline: 30 September 2020)
- MicroRNA as Biomarkers in Cancer Diagnostics and Therapeutics (II) (Deadline: 30 September 2020)
- Oral Fibrosis and Oral Cancer: From Molecular Targets to Therapeutics (Deadline: 30 September 2020)
- The Future of Cartilage Repair in Complex Biological Situations (Deadline: 30 September 2020)
- Molecular Biomarkers in Colorectal Adenocarcinoma (Deadline: 30 September 2020)
- Neuroinfectiology: Molecular and Cellular Mechanisms of Neurotropic Virus Infection 2.0 (Deadline: 1 October 2020)
- S-Glutathionylation in Redox Protein Signaling and Health Outcomes (Deadline: 15 October 2020)
- Metabesity and Tissue Regeneration: New Therapies for Emerging Challenges (Deadline: 15 October 2020)
- Molecular Research on Neurodegenerative Diseases 2.0 (Deadline: 15 October 2020)
- Pathophysiology, Molecular Mechanism and Therapeutic Strategies of Lysosomal Storage Disorders (LSD) (Deadline: 19 October 2020)
- Hydrogen Sulfide in the Diseases and Tissue Regeneration 2.0 (Deadline: 25 October 2020)
- Adrenal Disease beyond Arterial Hypertension: Metabolic and Cardiovascular Aspects (Deadline: 30 October 2020)
- Positive and Negative Determinants of Ischaemic Injury—Co-Morbidities and Cardioprotection 2020 (Deadline: 30 October 2020)
- Thyroid Cell: Genetic and Environmental Factors, Involved in its Damage (Deadline: 30 October 2020)
- Cellular and Molecular Mechanisms of Liver Regeneration (Deadline: 31 October 2020)
- Rescue Therapies and Molecular Mechanisms of Perinatal Brain Injury (Deadline: 31 October 2020)
- Retinal Function and Morphology in Health, Aging and Disease (Deadline: 31 October 2020)
- Metabolic Dysfunction in Multiple Sclerosis Disease Course and Progression (Deadline: 31 October 2020)
- Cancer Biology in Diabetes (Deadline: 31 October 2020)
- Mitogen Activated Protein Kinases: Functions in Signal Transduction and Human Diseases 2.0 (Deadline: 31 October 2020)
- Endocannabinoid System in Health and Disease: Current Situation and Future Perspectives 2.0 (Deadline: 31 October 2020)
- Transcriptional Therapy and Nucleic Acid-Based Therapeutics: From Molecular Targets to Preclinical Studies (Deadline: 31 October 2020)
- Transgenic Mice in Human Diseases: Insights from Molecular Research (Deadline: 31 October 2020)
- Mechanisms of Dry Eye Diseases (Deadline: 31 October 2020)
- Molecular Research on Pulmonary Hypertension 2.0 (Deadline: 31 October 2020)
- Pathophysiology in Colonic Diseases (Deadline: 31 October 2020)
- Insights into Photodynamic Therapy 2.0 (Deadline: 31 October 2020)
- Thyroid Hormone and Thyroid Hormone-Related Compounds: Molecular Pathways and Effects (Deadline: 31 October 2020)
- High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future (Deadline: 31 October 2020)
- Tumour Cell Dissemination in Bone: Pathophysiology and Therapeutic Strategies (Deadline: 31 October 2020)
- Molecular Imaging in Diabetes, Obesity, and Infections 2.0 (Deadline: 31 October 2020)
- Radiation in Multimodal Tumor Immune Therapies – Mechanisms and Application (Deadline: 31 October 2020)
- Molecular Research on Arteriosclerosis and Thrombosis (Deadline: 31 October 2020)
- Stroke: Merging Neuroprotection and Neuroregeneration towards Therapeutics (Deadline: 31 October 2020)
- Proteomics Analysis in Biomarker Discovery (Deadline: 31 October 2020)
- Insulin Pathways for Therapeutic Intervention (Deadline: 31 October 2020)
- Molecular Advances in Hypertension and Blood (Deadline: 31 October 2020)
- Aromatic Amino Acid Decarboxylase Deficiency: A Molecular, Cellular and Systemic Perspective (Deadline: 31 October 2020)
- Epigenetics in Metabolic and Neurological Disorders 2.0 (Deadline: 31 October 2020)
- Molecular Mechanism and Pathogenesis of Sarcopenia (Deadline: 31 October 2020)
- Notch Signaling as a Versatile Regulator of Organ Physiology and Pathology (Deadline: 31 October 2020)
- Molecular Pathology of Idiopathic Pulmonary Fibrosis (Deadline: 31 October 2020)
- Lypodistrophy and Fat Redistribution: From Molecular Basis to Therapies (Deadline: 31 October 2020)
- Recent Advances in Salivary Gland and Their Function (Deadline: 31 October 2020)
- Molecular Research on Stroke Prognosis, Complications, and Therapeutic Effects (Deadline: 31 October 2020)
- Rare Diseases - Molecular Mechanisms and Therapeutic Strategies (III) (Deadline: 31 October 2020)
- Positron Emission Tomography (PET) Molecular Imaging in Understanding Metabolic Disease (Deadline: 31 October 2020)
- Skin Epidermis and Barrier Function (Deadline: 31 October 2020)
- Molecular Mechanisms Underlying the Interaction between Mental Health and Cardiovascular Disease (Deadline: 31 October 2020)
- Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases (Deadline: 31 October 2020)
- Musculoskeletal Aging and Sarcopenia in the Elderly (Deadline: 31 October 2020)
- Recent Advances in Pathophysiology of Fibrosis and Scarring 2020 (Deadline: 31 October 2020)
- Metastasis Inhibition (Deadline: 31 October 2020)
- Skeletal Muscle Organelle Maintenance in Health and Disease: From Molecular Mechanisms to Practical Recommendations (Deadline: 15 November 2020)
- Congenital and Acquired Platelet Disease (Deadline: 15 November 2020)
- Cell Therapy Approaches for Bone and Cartilage Regeneration (Deadline: 15 November 2020)
- Extracellular Vesicles as a New Source of Liquid Biopsy (Deadline: 15 November 2020)
- Role of Environmental and Metabolic Factors in Inflammatory Bowel Disorders (Deadline: 15 November 2020)
- Hormones-Dependent Cancers: New Aspects on Biochemistry and Molecular Pathology 3.0 (Deadline: 15 November 2020)
- Circadian Clock and Reproduction (Deadline: 16 November 2020)
- Epigenetic Mechanisms and Human Pathology (Deadline: 20 November 2020)
- Molecular Research of Endometrial Pathophysiology 2.0 (Deadline: 30 November 2020)
- Inflammation in Health and Disease: New Insights and Therapeutic Avenues (Deadline: 30 November 2020)
- Oxidative Stress and Brain Injury 2.0 (Deadline: 30 November 2020)
- Dual Targeting as a Strategy to Counteract Chronic Diseases (Deadline: 30 November 2020)
- Membrane Channels in Health and Diseases (Deadline: 30 November 2020)
- Stem Cells — from Bench to Bedside (Deadline: 30 November 2020)
- New Regulators and Modulators of MicroRNA 2020 (Deadline: 30 November 2020)
- Head and Neck Cancers 2.0: Diagnostics, Prognostic Biomarkers and Therapeutic Advances for Primary Tumors and Metastasis (Deadline: 30 November 2020)
- Molecular Mechanisms of Periodontal Disease (Deadline: 30 November 2020)
- Gynecologic Oncology: From Molecular Mechanisms to Targeted Therapies 2020 (Deadline: 30 November 2020)
- Oxidative Stress and Inflammation in Chronic Diseases (Deadline: 30 November 2020)
- Molecular Research of Aging Stress Response (Deadline: 30 November 2020)
- Pro-inflammatory Nutrient: Focus on Gliadin and Celiac Disease (Deadline: 30 November 2020)
- Acute Kidney Injury Progression to Chronic Kidney and Cardiovascular Disease (Deadline: 30 November 2020)
- Glioblastoma – Pathogenesis, Cellular and Molecular Mechanism (Deadline: 30 November 2020)
- Bone Metastasis Challenge: New ideas and Future Perspectives (Deadline: 30 November 2020)
- Hepatitis B Virus and Carcinogenesis—Pathophysiology, Disease and Treatment (Deadline: 30 November 2020)
- Physiology of Platelets in Humans and Animals (Deadline: 30 November 2020)
- Redox Signaling and Oxidative Stress in Bone Health and Disease (Deadline: 30 November 2020)
- Retinal Degeneration: From Pathophysiology to Therapeutic Approaches 2.0 (Deadline: 30 November 2020)
- Amniotic Fluid and Placental Membranes as Sources of Stem Cells: Progress and Challenges (Deadline: 30 November 2020)
- Myelofibrosis and Myeloproliferative Neoplasms: Molecular Basis (Deadline: 30 November 2020)
- Molecular Research on the Effect of Dialysis on the Endothelial Cells (Deadline: 30 November 2020)
- The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles (Deadline: 30 November 2020)
- Sperm-Egg Adhesion and Fusion (Deadline: 30 November 2020)
- Molecular Mechanism of Alzheimer's Disease II (Deadline: 30 November 2020)
- The Emerging Role of HER2 and PD-1 in Cancers (Deadline: 30 November 2020)
- STATs in Cancer Microenvironment (Deadline: 1 December 2020)
- Studies on the Pathogenesis of Chromosome Rearrangement (Deadline: 10 December 2020)
- Endocannabinoids, Cannabinoids and Psychiatry: Biological Mechanisms (Deadline: 15 December 2020)
- Stem Cells Aging (Deadline: 30 December 2020)
- Neuron and Brain Maturation (Deadline: 30 December 2020)
- Pathophysiology of Esophageal Adenocarcinoma (Deadline: 31 December 2020)
- Environmental Sensitivity Illnesses: Mechanisms and Molecular Signatures 2.0 (Deadline: 31 December 2020)
- Renin-Angiotensin-Aldosterone System: Friend or Foe—The Matter of Balance (Deadline: 31 December 2020)
- Oxidative Stress and Lung Injury (Deadline: 31 December 2020)
- Molecular Basis of Platelet Function in Thrombosis and beyond (Deadline: 31 December 2020)
- Molecular Decision Making in the Treatment of Colorectal Liver Metastases (Deadline: 31 December 2020)
- Rare Kidney Diseases: New Translational Research Approach to Improve Diagnosis and Therapy 2.0 (Deadline: 31 December 2020)
- Role of the Extracellular Vesicles Shed by Adipose Tissue in Obesity (Deadline: 31 December 2020)
- Novel Molecular Targets for Cardioprotection 2020: The EU-CARDIOPROTECTION COST Action (CA16225) (Deadline: 31 December 2020)
- Molecular Mechanisms of Ovarian Cancer Development and Metastasis 2.0 (Deadline: 31 December 2020)
- Role of Extracellular Vesicles in Tumor Microenvironment (Deadline: 31 December 2020)
- Aging and Senescence (Deadline: 31 December 2020)
- Hypertension and Cardiovascular Diseases: From Etiopathogenesis to Potential Therapeutic Targets 2020 (Deadline: 31 December 2020)
- The Role of Stromal Microenvironment in Tumour Angiogenesis: Biological Pathways and Therapeutic Implications (Deadline: 31 December 2020)
- Molecular Research on Lymphedema (Deadline: 31 December 2020)
- Molecular Bases of Health Disparities in Digestive Diseases (Deadline: 31 December 2020)
- Diabetic Retinopathy: Mechanisms underlying Pathophysiology and Therapies 2.0 (Deadline: 31 December 2020)
- Germ Cells Development and Their Cancers (Deadline: 31 December 2020)
- Molecular Mechanisms and Biomarkers in Drug-Induced Organ Injury (Deadline: 31 December 2020)
- The Link between Obesity, Diabetes and Inflammation: Molecular Aspects (Deadline: 31 December 2020)
- Atherosclerosis: Form Molecular Biology to Therapeutic Perspective (Deadline: 31 December 2020)
- Molecular and Cellular Mechanisms in Inflammatory Synaptopathy (Deadline: 31 December 2020)
- Promising Molecular Targeted Strategies Disrupting Tumour-Microenvironment Communication in Solid Tumours (Deadline: 31 December 2020)
- Impact of Cholesterol and Sterol Derivatives on Pathogenetic Mechanisms and on the Therapy of Neuropsychiatric Diseases (Deadline: 31 December 2020)
- Ferroportin and Ceruloplasmin: Structure and Function in Health and Disease (Deadline: 31 December 2020)
- Amyotrophic Lateral Sclerosis (Deadline: 31 December 2020)
- Molecular, Cellular and Systemic Signature of Microglia (Deadline: 31 December 2020)
- Mastocytosis, MCAS, and Related Disorders – Diagnosis, Classification and Therapy (Deadline: 31 December 2020)
- Old and New Players in Inflammatory Disorders as Tools for Prevention, Diagnosis, and Treatment (Deadline: 31 December 2020)
- Misfolding Diseases, Intracellular Trafficking and Therapeutic Approaches (Deadline: 31 December 2020)
- Cell Block in Tumor Pathology, Molecular Diagnostics and Analysis (Deadline: 31 December 2020)
- Mechanisms of Cancer Development in Diabetes (Deadline: 31 December 2020)
- New Frontiers of Traumatic Brain Injury Management (Deadline: 31 December 2020)
- Tumor Microenvironment from a Precision Medicine Perspective (Deadline: 31 December 2020)
- Neutrophils in Cardiovascular Diseases (Deadline: 31 December 2020)
- Epithelium-Immune Cell Interactions Underlying Innate and Adaptive Immunity (Deadline: 31 December 2020)
- Cell Signalling in Cancer: Organelles and Beyond (Deadline: 31 December 2020)
- Telomere Homeostasis in Ageing Related Pathologies (Deadline: 30 January 2021)
- Sarcopenic Obesity: Mechanisms and Countermeasures (Deadline: 31 January 2021)
- Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases (Deadline: 31 January 2021)
- Molecular Mechanisms in Cancer Metastasis II (Deadline: 31 January 2021)
- Molecular Mechanisms of Drug-Induced, Immune-Mediated Liver Injury (Deadline: 31 January 2021)
- Inflammaging, Cellular Senescence and Oxidative Stress in Aging and Age-Related Disorders (Deadline: 31 January 2021)
- Molecular Recognition in Protein and Peptide Nanotechnology (Deadline: 31 January 2021)
- Molecular Mechanisms on Blood-Brain Barrier (BBB) (Deadline: 31 January 2021)
- Amyloid Hetero-Aggregation (Deadline: 28 February 2021)
- Molecular Research in Medical Genetics (Deadline: 28 February 2021)
- Diabetic Liver Disease (Deadline: 28 February 2021)
- New Paradigms in the Management of Hemoglobinopathies (Deadline: 28 February 2021)
- Pathogenic Mechanisms of Muscle Diseases (Deadline: 31 March 2021)
Topical Collections
Following topical collections within this section are currently open for submissions:
